Breaking News

AMRI Becomes Curia

New brand reinforces ongoing expansion of expertise, capabilities and contributions to health care.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Albany Molecular Research, Inc. (AMRI), a global contract research, development and manufacturing organization serving the pharmaceutical and biopharmaceutical industries, is changing its name to Curia, effective July 12, 2021. The new name reinforces the company’s positioning as an end-to-end global CDMO, applying its scientific expertise and extensive capabilities from research and development (R&D) through to commercial manufacturing to enable its pharmaceutical and biotechnology customer...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters